Cargando…

Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer

Locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous disease, and we have embarked on an era where patients will benefit from individualized therapeutic strategies based on identifiable molecular characteristics of the tumor. The landmark studies demonstrating the importance of mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, D. Nathan, Nam, Taek-Keun, Choe, Kevin S., Choy, Hak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394867/ https://www.ncbi.nlm.nih.gov/pubmed/22802745 http://dx.doi.org/10.4143/crt.2012.44.2.74

Ejemplares similares

Recent Advances in Combined Modality Therapy
por: Mierzwa, Michelle L., et al.
Publicado: (2010)

Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
por: Lee, Hyunjong, et al.
Publicado: (2022)

Molecular Therapeutic Advances in Personalized Therapy of Melanoma and Non-Small Cell Lung Cancer
por: Kelleher, Fergal C., et al.
Publicado: (2012)

Effect of PF-02341066 and radiation on non-small cell lung cancer cells
por: TUMATI, VASU, et al.
Publicado: (2013)

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer
por: Kang, Byung-Hee, et al.
Publicado: (2022)

Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
por: Zhang, Zhenyang, et al.
Publicado: (2020)

Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes
por: Jin, Yonglong, et al.
Publicado: (2023)

Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy
por: TUMATI, VASU, et al.
Publicado: (2013)

Combined modality therapy in Stage IIIA non–small cell lung cancer: clarity or confusion despite the highest level of evidence?
por: Jeremic, Branislav, et al.
Publicado: (2017)

Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case report
por: Yang, Jie, et al.
Publicado: (2021)

Cross-Modality Person Re-Identification Based on Heterogeneous Center Loss and Non-Local Features
por: Han, Chengmei, et al.
Publicado: (2021)

Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer
por: Ebinç, Senar, et al.
Publicado: (2023)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
por: Moya-Horno, Irene, et al.
Publicado: (2018)

Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib
por: Mu, Yuxin, et al.
Publicado: (2019)

Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer
por: Qiu, Guanhua, et al.
Publicado: (2022)

Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
por: Turtle, Louise, et al.
Publicado: (2021)

Optimizing the management of advanced non-small-cell lung cancer: a personal view
por: Vincent, M.D.
Publicado: (2009)

Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice
por: Pirker, Robert, et al.
Publicado: (2016)

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)

Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Lee, Nam Kwon, et al.
Publicado: (2014)

Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond
por: Chi, Alexander, et al.
Publicado: (2014)

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
por: Sultana, A, et al.
Publicado: (2007)

Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy
por: Agrawal, Sushma, et al.
Publicado: (2014)

How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer
por: Kunitoh, H, et al.
Publicado: (2007)

Effects of β-Adrenergic Antagonists on Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
por: Chaudhary, Kunal R., et al.
Publicado: (2019)

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer
por: Chun, Stephen G., et al.
Publicado: (2017)

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
por: Rico, Mikel, et al.
Publicado: (2021)

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study
por: Scinto, A F, et al.
Publicado: (1999)

Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
por: Zhang, Luping, et al.
Publicado: (2016)

Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review
por: Yin, Cunli, et al.
Publicado: (2023)

Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer
por: Cheng, Lei, et al.
Publicado: (2023)

A Case of Five-Year Survival After Combined-Modality Treatment for Non-Small Cell Lung Cancer With Intraspinal Metastasis
por: Nieder, Carsten, et al.
Publicado: (2022)

Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
por: Rangamuwa, Kanishka, et al.
Publicado: (2021)

Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer
por: Kim, Myungsoo, et al.
Publicado: (2011)

Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
por: Agrawal, Sushma
Publicado: (2013)

Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
por: Woodford, Katrina, et al.
Publicado: (2017)

Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: “MTD” or “ALARA”?
por: Ohri, Nitin
Publicado: (2017)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qiljpkjs7716jn1nqqkc1p21hl